Neuburgh Advisers LLC Buys 2,080 Shares of Simulations Plus, Inc. (NASDAQ:SLP)

Neuburgh Advisers LLC increased its stake in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 419.4% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 2,576 shares of the technology company’s stock after purchasing an additional 2,080 shares during the quarter. Neuburgh Advisers LLC’s holdings in Simulations Plus were worth $74,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Campbell & CO Investment Adviser LLC increased its position in shares of Simulations Plus by 13.0% during the 2nd quarter. Campbell & CO Investment Adviser LLC now owns 23,221 shares of the technology company’s stock valued at $663,000 after purchasing an additional 2,669 shares during the last quarter. Wasatch Advisors Inc. increased its position in shares of Simulations Plus by 15.6% during the 1st quarter. Wasatch Advisors Inc. now owns 343,122 shares of the technology company’s stock valued at $7,243,000 after purchasing an additional 46,310 shares during the last quarter. William Blair Investment Management LLC increased its position in shares of Simulations Plus by 8.8% during the 1st quarter. William Blair Investment Management LLC now owns 485,040 shares of the technology company’s stock valued at $10,239,000 after purchasing an additional 39,114 shares during the last quarter. Bahl & Gaynor Inc. increased its position in shares of Simulations Plus by 10.7% during the 2nd quarter. Bahl & Gaynor Inc. now owns 124,012 shares of the technology company’s stock valued at $3,542,000 after purchasing an additional 11,968 shares during the last quarter. Finally, Crawford Investment Counsel Inc. increased its position in shares of Simulations Plus by 6.0% during the 1st quarter. Crawford Investment Counsel Inc. now owns 355,057 shares of the technology company’s stock valued at $7,495,000 after purchasing an additional 20,009 shares during the last quarter. 41.97% of the stock is currently owned by hedge funds and other institutional investors.

In related news, Director John Kenneth Paglia sold 690 shares of the business’s stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $37.86, for a total transaction of $26,123.40. Following the completion of the transaction, the director now owns 2,112 shares in the company, valued at approximately $79,960.32. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Walter S. Woltosz sold 24,000 shares of the business’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $36.22, for a total value of $869,280.00. The disclosure for this sale can be found here. 31.57% of the stock is owned by insiders.

SLP traded down $0.26 during trading hours on Friday, reaching $34.38. 2,535 shares of the company’s stock traded hands, compared to its average volume of 114,977. The firm has a 50-day moving average price of $36.95 and a 200 day moving average price of $27.58. Simulations Plus, Inc. has a 52-week low of $17.18 and a 52-week high of $41.95. The firm has a market capitalization of $585.90 million, a PE ratio of 68.80 and a beta of -0.35.

Simulations Plus (NASDAQ:SLP) last posted its quarterly earnings data on Wednesday, July 10th. The technology company reported $0.16 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.14 by $0.02. Simulations Plus had a return on equity of 23.48% and a net margin of 24.09%. The company had revenue of $9.94 million during the quarter, compared to analysts’ expectations of $9.85 million. Sell-side analysts forecast that Simulations Plus, Inc. will post 0.46 EPS for the current fiscal year.

Several equities analysts have recently weighed in on SLP shares. Zacks Investment Research raised Simulations Plus from a “hold” rating to a “strong-buy” rating and set a $37.00 target price on the stock in a research report on Friday, July 19th. BidaskClub downgraded Simulations Plus from a “strong-buy” rating to a “buy” rating in a research report on Tuesday. Finally, ValuEngine downgraded Simulations Plus from a “strong-buy” rating to a “buy” rating in a research report on Friday, August 2nd.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for mechanistic modeling and simulation, and machine-learning-based prediction of properties of molecules from their structure worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments that measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments.

Read More: What is a growth and income fund?

Want to see what other hedge funds are holding SLP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Simulations Plus, Inc. (NASDAQ:SLP).

Institutional Ownership by Quarter for Simulations Plus (NASDAQ:SLP)

Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.